This test was conducted using a dynamic model of the upper gastrointestinal tract (TIM-1 test). It compares the bioaccessibility rates of different compounds in a scientific manner. The test concluded that each milligram of OleoCBD™ is 2x more bioaccessible than CBD isolate. On pages 9 and 17 you’ll find pictures of the machine used to conduct the test as well as charts comparing the bioaccessibility rates over time. View the PDF version below or download it here.